| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | positive allosteric modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | potentiator |
| propofol | gamma-aminobutyric acid receptor subunit beta-2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | potentiator,positive modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | potentiator,positive modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | potentiator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational,vet_approved | positive allosteric modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | positive allosteric modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | positive allosteric modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-3 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | potentiator,positive modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-3 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | potentiator |
| propofol | gamma-aminobutyric acid receptor subunit beta-3 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | potentiator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gamma-aminobutyric acid receptor subunit beta-3 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | approved,investigational,vet_approved | potentiator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.03 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational,vet_approved | positive allosteric modulator,positive modulator |
| propofol | sodium channel protein type 2 subunit alpha | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved,investigational,vet_approved | inhibitor |
| propofol | sodium channel protein type 2 subunit alpha | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved,investigational,vet_approved | inhibitor |
| propofol | sodium channel protein type 4 subunit alpha | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved,investigational,vet_approved | inhibitor |
| propofol | sodium channel protein type 4 subunit alpha | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Status Epilepticus[MeSHID:D013226] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved,investigational,vet_approved | inhibitor |
| click here to return to the previous page | ||||||||